Available Structures

62 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal Structure of activated receptor tyrosine kinase in complex with substrates Heteromer
P10686;
DVT;ACP;MG;464-770
Assess
Crystal structure of a monomeric human FGF9 in complex with the ectodomain of human FGFR1c Heteromer
P31371;
SO4;147-360
Assess
CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1… Heteromer
P05230;
SO4;147-359
Assess
Crystal Structure of a 1:1:1 FGF23-FGFR1c-aKlotho Ternary Complex Heteromer
Q9GZV9; Q9UEF7;
NAG;ZN;149-361
Assess
CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX Heteromer
P09038;
SO4;149-359
Assess
CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX Heteromer
P09038;
SGN;SGN;149-359
Assess
Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors Heteromer
Q8WU20;
409-430
Assess
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…homo-2-merSO4;EDO;2K7;458-765
Assess
Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5…homo-2-merVM1;PO4;459-765
Assess
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…homo-2-merSO4; 10×EDO;0S9;460-765
Assess
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…homo-2-merEDO;SO4;2K5;460-765
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1homo-2-mer461-762
Assess
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…homo-2-mer0S8;EDO;SO4;461-762
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074homo-2-merPD1;461-762
Assess
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…homo-2-mer0S7;EDO;461-762
Assess
Crystal Structure of activated receptor tyrosine kinase in complex with substratesmonomerGQL;463-774
Assess
Native FGFR1 with an inhibitormonomerCL;38O;458-765
Assess
FGFR1 mutant with an inhibitormonomer38O;CL;458-764
Assess
Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETH…monomer66T;458-764
Assess
Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domainmonomerSO4;458-764
Assess
Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-…monomer66T;MG;458-764
Assess
Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apomonomer460-764
Assess
Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethox…monomer07J;SO4;461-765
Assess
Structure of the mutant Fibroblast Growth Factor receptor 1monomer461-765
Assess
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.monomerSO4;EDO;O21;462-765
Assess
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527monomer9ES;SO4;EDO;463-765
Assess
DISEASE LINKED MUTATION IN FGFRmonomerSO4;ACT;460-762
Assess
FGFR1 in complex with dovitinibmonomerEDO;38O;SO4;464-766
Assess
FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylph…monomerSO4;XL6;463-765
Assess
FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693monomerSO4;5SF;464-765
Assess
Crystal structure of FGFR1 kinase domain in complex with compound 3monomerAXU;464-765
Assess
TAS-120 in reversible binding mode with FGFR1monomerTZ0;464-765
Assess
Crystal structure of FGFR1 kinase domain in complex with 7nmonomer4UT;464-765
Assess
FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindolemonomerC4F;464-765
Assess
FGFR1 ligand complexmonomerSO4;EDO;XOJ;464-765
Assess
FGFR1 kinase complex with inhibitor SN36985monomerYY7;SO4;464-765
Assess
FGFR1 kinase domain complex with SN37333 in reversible binding modemonomerYY9;464-765
Assess
TAS-120 covalent complex with FGFR1monomerTZ0;SO4;464-765
Assess
FGFR1 kinase domain complexed with FIIN-1monomerMK9;SO4;464-765
Assess
FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamidemonomerWP1;464-765
Assess
Fibroblast growth factor receptor 1 kinase in complex with JK-P5monomerEDO;JVT;SO4;464-765
Assess
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.monomerO1Y;SO4;462-763
Assess
Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-…monomer66T;465-765
Assess
Human FGF in complex with a covalent inhibitormonomer9K5;SO4;464-764
Assess
Fibroblast growth factor receptor 1 kinase in complex with JK-P3monomerEDO;4Y0;PPI;SO4;465-765
Assess
FGFR1 kinase complex with inhibitor SN37118monomerYY4;465-765
Assess
Human FGF in complex with a covalent inhibitormonomerSO4;GOL;9K8;464-764
Assess
Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069monomer3RH;SO4;EDO;461-761
Assess
FGFR1 kinase complex with inhibitor SN37116monomerYY6;465-765
Assess
Crystal structure of FGFR1 (C488A, C584C) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-met…monomer465-765
Assess
FGFR1 kinase complex with inhibitor SN37115monomerYY5;SO4;465-765
Assess
FGFR1 Apo structuremonomerPEG;CL;462-762
Assess
Human FGFR1 kinase in complex with CH5183284monomerLWJ;SO4;464-763
Assess
FGFR-1 in complex with ligand lenvatinibmonomerLEV;463-762
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W…monomerSU2;464-762
Assess
Crystal structure of FGFR1 kinase domain in complex with a novel inhibitormonomer960;464-762
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W…monomerSU1;464-762
Assess
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…monomer2M2;465-762
Assess
Solution structure of the first Ig-like domain of human fibroblast growth factor receptor 1monomer38-123
Assess
cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-pi…monomerACT;KRJ;577-597
Assess
cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2…monomerKRL;SO4;577-597
Assess
cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitormonomerSO4;8C5;585-597
Assess

51 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2homo-2-merMG;0.776v6q.1.A461-761
78.66
Assess
Isoform 2monomer0.641ry7.1.B152-361
58.41
Assess
Isoform 3homo-2-merMG;0.776v6q.1.A374-674
81.45
Assess
Isoform 3monomer0.675w59.1.B58-271
99.11
Assess
Isoform 4homo-2-merMG;0.776v6q.1.A372-672
78.66
Assess
Isoform 4monomer0.695w59.1.B58-271
99.11
Assess
Isoform 5homo-2-merMG;0.786v6q.1.A303-603
81.25
Assess
Isoform 6homo-2-merMG;0.786v6q.1.A301-601
78.66
Assess
Isoform 7homo-2-merMG;0.776v6q.1.A461-761
81.45
Assess
Isoform 7monomer0.651ry7.1.B150-359
56.92
Assess
Isoform 8monomer0.685a46.1.A464-646
88.52
Assess
Isoform 8monomer0.563b43.1.A33-361
22.58
Assess
Isoform 8monomer0.545xwu.1.C32-359
22.42
Assess
Isoform 8monomer0.534pbx.1.A36-360
22.94
Assess
Isoform 9monomer0.685a46.1.A462-644
88.94
Assess
Isoform 9monomer0.553b43.1.A33-361
22.58
Assess
Isoform 9monomer0.555xwu.1.A32-360
22.34
Assess
Isoform 9monomer0.522yd9.1.A32-357
22.94
Assess
Isoform 9monomer0.524pbx.1.A36-361
22.86
Assess
Isoform 10monomer0.723ojm.1.B62-273
69.52
Assess
Isoform 10monomer0.704j96.1.A369-559
72.54
Assess
Isoform 10monomer0.691e0o.1.B62-270
78.67
Assess
Isoform 10monomer0.575y32.1.B87-273
30.05
Assess
Isoform 11monomer0.723ojm.1.B62-272
69.86
Assess
Isoform 11monomer0.704j96.1.A367-557
72.02
Assess
Isoform 11monomer0.691e0o.1.B62-270
78.67
Assess
Isoform 11monomer0.575y32.1.B87-273
30.05
Assess
Isoform 12monomer0.714j96.1.A298-489
71.65
Assess
Isoform 12monomer0.703ojm.1.B2-202
69.35
Assess
Isoform 12monomer0.671e0o.1.B1-199
79.10
Assess
Isoform 12monomer0.575y32.1.B16-202
30.05
Assess
Isoform 13monomer0.714j96.1.A296-486
70.62
Assess
Isoform 13monomer0.703ojm.1.B3-201
69.54
Assess
Isoform 13monomer0.671e0o.1.B1-199
79.10
Assess
Isoform 13monomer0.565y32.1.B16-202
30.05
Assess
Isoform 14homo-2-merMG;0.776v6q.1.A372-672
81.45
Assess
Isoform 14monomer0.693ojv.2.B58-268
99.55
Assess
Isoform 15monomer0.712ckn.1.A35-119
94.12
Assess
Isoform 16monomer0.721cvs.1.C60-271
77.27
Assess
Isoform 16monomer0.703grw.1.A63-270
53.92
Assess
Isoform 16monomer0.701e0o.1.B62-271
60.75
Assess
Isoform 17monomer0.582y8n.1.B31-57
37.04
Assess
Isoform 18monomer0.731cvs.1.C59-269
76.74
Assess
Isoform 18monomer0.713grw.1.A61-268
53.92
Assess
Isoform 18monomer0.711e0o.1.B59-269
60.47
Assess
Isoform 19homo-2-merMG;0.766v6q.1.A463-763
81.45
Assess
Isoform 19monomer0.701cvs.1.C151-358
88.69
Assess
Isoform 20homo-2-merMG;0.776v6q.1.A453-753
78.66
Assess
Isoform 20monomer0.651ry7.1.B144-353
57.63
Assess
Isoform 21homo-2-merMG;0.776v6q.1.A494-794
81.45
Assess
Isoform 21monomer0.631ry7.1.B183-395
62.63
Assess

Alignments